AMANDA V BURNETT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health LAKE CHARLES, LA NPI 1235452822
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health LA Acerta Pharma LLC All categories
General Payments — all program years on this page
$6,916.51
- Category: General Payments
- Program years: PY2021–2024
- Record count: 343
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,423.31 across 66 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,414.41 | 65 |
| Education | $8.90 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $276.47 | 8 |
| Novo Nordisk AS | $233.26 | 9 |
| Amgen Inc. | $160.13 | 14 |
| Lilly USA, LLC | $157.96 | 9 |
| Abbott Laboratories | $151.81 | 4 |
| Astellas Pharma US Inc | $74.71 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.20 | 4 |
| ABBVIE INC. | $55.29 | 2 |
| Xeris Pharmaceuticals, Inc. | $42.19 | 2 |
| Corcept Therapeutics | $34.76 | 2 |
| Sumitomo Pharma America, Inc. | $23.44 | 1 |
| Pacira Pharmaceuticals Incorporated | $22.53 | 1 |
| GENZYME CORPORATION | $22.20 | 1 |
| ConvaTec Inc. | $17.74 | 1 |
| DEXCOM, INC. | $16.81 | 1 |
| Esperion Therapeutics, Inc. | $15.68 | 1 |
| Supernus Pharmaceuticals, Inc. | $15.61 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.82 | 1 |
| GlaxoSmithKline, LLC. | $14.70 | 1 |
By program year
Records — PY2024 (66)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.